Pharmaceutical Price Regulation Scheme:Written question - 138517

Asked by Derek Thomas
(St Ives)
Asked on: 26 April 2018
Department of Health and Social Care
Pharmaceutical Price Regulation Scheme
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that improving patient access to innovative new medicines is included in the terms of reference for negotiations on the pharmaceutical price regulation scheme.
Answered by: Steve Brine
Answered on: 03 May 2018

The current Pharmaceutical Price Regulation Scheme has seen the Department prioritise rapid access to innovative, new, cost-effective medicines that improve patient outcomes, including a provision for companies to propose Patient Access Schemes to help make sure these treatments can be made widely available in the National Health Service. This has been supported by a broader range of initiatives including the Cancer Drugs Fund and the new Accelerated Access Collaborative.

The Department will shortly be formally agreeing the structure and topics for negotiation with industry on the successor to the current Pharmaceutical Price Regulation Scheme, following the informal discussions which have already begun.

Share this page